Microarray analysis of lung long non-coding RNAs in cigarette smoke-exposed mouse model
Hao Wang(Chengdu Women's and Children's Central Hospital), Fuqiang Wen(Sichuan University), Dan Xu(Northwestern University), Diandian Li(Sichuan University), Lei Chen(Zhuzhou Central Hospital), Tao Wang(Heilongjiang University of Chinese Medicine), Ni Zeng(Sichuan University), Yanqiu Wu, Yongchun Shen(Sichuan University)
Cited by 11
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934